glp-1 vs sglt2 diabetes Inhibitors vs. Agonists to Treat the Heart, the Kidneys and the Brain SGLT2 inhibitors and GLP-1 receptor
Description
Current data suggest that obesity is a chronic relapsing disease
Arlington and the Mid-Cities fill in the middle
PlexusDx recommends discussing your symptom timeline with your care team
2021;161(6):184252 e10
While GLP-1s are popular right now and have helped many people lose weight, the side effects are still being studied
Weight-bearing exercise should be avoided in active foot disease
